EvidScience
Latest round
- Seed
Last raised
- Mar 2019
Total raised
- Undisclosed
Investors
- 4
About EvidScience
EvidScience Inc.Founded in 2017 and headquartered in El Segundo, US, EvidScience Inc. focuses on leveraging artificial intelligence to improve healthcare data insights. The company was acquired by Genesis Research LLC in January 2021, which emphasized a strategic pivot towards integrating AI with human intelligence for more comprehensive data analysis.EvidES by Genesis Research specializes in advanced artificial intelligence solutions, primarily focused on enhancing data analysis and decision-making processes within the healthcare sector. Their core product, EVID AI, leverages machine learning algorithms to analyze large volumes of clinical data, providing insights that streamline research and improve patient outcomes. The platform is designed to address critical use cases such as accelerating drug discovery, optimizing clinical trial designs, and enhancing real-world evidence generation. The company serves a diverse client base, including pharmaceutical companies, biotechnology firms, and academic institutions, primarily in North America and Europe.EvidES generates revenue primarily through a subscription-based model, where clients pay for access to their EVID AI platform and associated services. These subscriptions may vary based on the level of service, including options for enterprise solutions that provide comprehensive access to the platform’s capabilities. Additionally, the company might engage in partnerships with pharmaceutical companies, offering tailored solutions to meet specific research needs, which could further enhance their revenue streams. The transactions typically involve annual contracts, with pricing plans structured around the volume of data processed and the specific functionalities utilized by the clients.In 2021, following the acquisition by Genesis Research LLC, EvidScience Inc. aims to innovate further by integrating AI with human intelligence for enhanced data extraction capabilities. Upcoming product enhancements and expansions into new markets are planned, although specific launch dates and targeted regions are not yet specified.
Who invested in EvidScience
4 investors across 2 rounds
See all investors in EvidScience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EvidScience
Who invested in EvidScience?
EvidScience has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EvidScience raised?
EvidScience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did EvidScience last raise money?
EvidScience's most recent round on record is a Seed, in Mar 2019.
What does EvidScience do?
EvidScience is a healthcare it company.
Where is EvidScience headquartered?
EvidScience is headquartered in El Segundo, US.
Which VCs invest in companies like EvidScience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at EvidScience's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like EvidScience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.